Search research articles
Contact Us
Filters
Showing results (1-10 of 14) with videos related to
Page
of 2
Sort By:
Nature Reviews. Drug Discovery
|
March 26, 2004
Cytokine-receptor pairing: accelerating discovery of cytokine function
Don Foster, Julia Parrish-Novak, Brian Fox, et al.
Cancer Journal (Sudbury, Mass.)
|
June 8, 2015
Image-Guided Tumor Resection
Julia Parrish-Novak, Eric C Holland, James M Olson
Journal of Leukocyte Biology
|
November 14, 2002
Interleukin-21 and the IL-21 receptor: novel effectors of NK and T cell responses
Julia Parrish-Novak, Donald C Foster, Richard D Holly, et al.
Neurosurgical Focus
|
February 4, 2014
Near-infrared imaging of brain tumors using the Tumor Paint BLZ-100 to achieve near-complete resection of brain tumors
Pramod V Butte, Adam Mamelak, Julia Parrish-Novak, et al.
JAMA Otolaryngology-- Head & Neck Surgery
|
February 20, 2016
Fluorescence Identification of Head and Neck Squamous Cell Carcinoma and High-Risk Oral Dysplasia With BLZ-100, a Chlorotoxin-Indocyanine Green Conjugate
Fred M Baik, Stacey Hansen, Sue E Knoblaugh, et al.
The Journal of Biological Chemistry
|
September 28, 2002
Interleukins 19, 20, and 24 signal through two distinct receptor complexes. Differences in receptor-ligand interactions mediate unique biological functions
Julia Parrish-Novak, Wenfeng Xu, Ty Brender, et al.
Cancer Research
|
October 17, 2015
Preclinical Validation of the Utility of BLZ-100 in Providing Fluorescence Contrast for Imaging Spontaneous Solid Tumors
Janean Fidel, Katie C Kennedy, William S Dernell, et al.
Journal of Neurosurgery. Pediatrics
|
August 29, 2025
Phase 1 and expanded imaging study of tozuleristide in patients with pediatric primary central nervous system tumors
Amy Lee, Bonnie L Cole, Jeffrey Ojemann, et al.
Contemporary Clinical Trials Communications
|
August 17, 2021
A first-in-human study of BLZ-100 (tozuleristide) demonstrates tolerability and safety in skin cancer patients
Miko Yamada, Dennis M Miller, Melinda Lowe, et al.
International Journal of Toxicology
|
April 14, 2017
Nonclinical Profile of BLZ-100, a Tumor-Targeting Fluorescent Imaging Agent
Julia Parrish-Novak, Kelly Byrnes-Blake, Narine Lalayeva, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 14) with videos related to
Sort By:
Page
of 2
Nature Reviews. Drug Discovery
|
March 26, 2004
Cytokine-receptor pairing: accelerating discovery of cytokine function
Don Foster, Julia Parrish-Novak, Brian Fox, et al.
Cancer Journal (Sudbury, Mass.)
|
June 8, 2015
Image-Guided Tumor Resection
Julia Parrish-Novak, Eric C Holland, James M Olson
Journal of Leukocyte Biology
|
November 14, 2002
Interleukin-21 and the IL-21 receptor: novel effectors of NK and T cell responses
Julia Parrish-Novak, Donald C Foster, Richard D Holly, et al.
Neurosurgical Focus
|
February 4, 2014
Near-infrared imaging of brain tumors using the Tumor Paint BLZ-100 to achieve near-complete resection of brain tumors
Pramod V Butte, Adam Mamelak, Julia Parrish-Novak, et al.
JAMA Otolaryngology-- Head & Neck Surgery
|
February 20, 2016
Fluorescence Identification of Head and Neck Squamous Cell Carcinoma and High-Risk Oral Dysplasia With BLZ-100, a Chlorotoxin-Indocyanine Green Conjugate
Fred M Baik, Stacey Hansen, Sue E Knoblaugh, et al.
The Journal of Biological Chemistry
|
September 28, 2002
Interleukins 19, 20, and 24 signal through two distinct receptor complexes. Differences in receptor-ligand interactions mediate unique biological functions
Julia Parrish-Novak, Wenfeng Xu, Ty Brender, et al.
Cancer Research
|
October 17, 2015
Preclinical Validation of the Utility of BLZ-100 in Providing Fluorescence Contrast for Imaging Spontaneous Solid Tumors
Janean Fidel, Katie C Kennedy, William S Dernell, et al.
Journal of Neurosurgery. Pediatrics
|
August 29, 2025
Phase 1 and expanded imaging study of tozuleristide in patients with pediatric primary central nervous system tumors
Amy Lee, Bonnie L Cole, Jeffrey Ojemann, et al.
Contemporary Clinical Trials Communications
|
August 17, 2021
A first-in-human study of BLZ-100 (tozuleristide) demonstrates tolerability and safety in skin cancer patients
Miko Yamada, Dennis M Miller, Melinda Lowe, et al.
International Journal of Toxicology
|
April 14, 2017
Nonclinical Profile of BLZ-100, a Tumor-Targeting Fluorescent Imaging Agent
Julia Parrish-Novak, Kelly Byrnes-Blake, Narine Lalayeva, et al.
Page
of 2